CBLL

Ceribell, Inc.

NasdaqHealthcareElectromedical & Electrotherapeutic Apparatus

Insider activity for last month from 09/20 to 10/20.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$119k1 sells
Net open-market−$119kBuying minus selling
Active insiders1Distinct reporting owners

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Oct 02, 2026

Open-market transaction mix · 1 transactions in the selected period
0 buys0%·100%1 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Sep 2026000$0$0$0
Oct 2026010$0$119k-$119k

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (1)
Sep 2026: 0 insidersOct 2026: 1 insiders
Sep 2026Oct 2026
1distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
1 insiders
  • WR
    Woo RaymondCTO · 0 buys · 1 sells · 0 awards (A)
    -$101.3klast 10/02/2026

CBLL transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
CompanyInsiderActivityDisclosed valueFiled (ET)
CBLLCeribell, Inc.
Woo RaymondCTOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
CBLLCeribell, Inc.
Woo RaymondCTOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
CBLLCeribell, Inc.
Woo RaymondCTOS · sale10b5-1 detectedSEC filing ↗-$119kView disclosure →
CBLLCeribell, Inc.
Woo RaymondCTOM · exercise10b5-1 detectedSEC filing ↗$108View disclosure →
CBLLCeribell, Inc.
Woo RaymondCTOM · exercise10b5-1 detectedSEC filing ↗$17.7kView disclosure →

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 5 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$119k
10b5-1 detected5
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
5transactionstxns
  • M · Option exercise · dominant4 · 80%
  • S · Open-market sells1 · 20%

Activity by reported role

A joint filing can contribute to multiple roles
CTO5

Reported Holdings After

Separated by insider, security, and ownership type

Woo RaymondCommon Stock · Direct
208.0k203.1kOct 01, 2026Oct 01, 2026
203,118Oct 01, 2026
Woo RaymondStock Option (Right to Buy) · Direct
48.6k19.0kOct 01, 2026Oct 01, 2026
19,021Oct 01, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Sep 20 → Oct 20
LessMore

Ceribell, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Ceribell, Inc.?

Woo Raymond.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Woo Raymond reported a sale on Oct 01, 2026 valued at $119k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $119,145.06. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.